To further investigate the mechanisms through which SB225002 inhibits NPC tumour growth and increases radiosensitivity in vivo, we selected two well defined markers of angiogenesis, CD31 and VEGF, to evaluate angiogenesis in the tumor sections. Here, VEGFA is linked to nasopharyngeal carcinoma.